Growth Metrics

DBV Technologies (DBVT) Free Cash Flow (2014 - 2026)

DBV Technologies (DBVT) reported Free Cash Flow of -$49.5 million for Q1 2026, down 151.27% year-over-year from $96.5 million in Q1 2025, and down 39.26% on a QoQ basis from -$35.5 million in Q4 2025.

DBV Technologies (DBVT) has 13 years of Free Cash Flow data on file, last reported at -$49.5 million in Q1 2026.

  • Quarterly Free Cash Flow fell 151.27% year-over-year to -$49.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$151.5 million (down 67.45% YoY) and the FY2025 annual result came in at -$121.7 million, down 13.95% from the prior year.
  • Free Cash Flow retreated to -$49.5 million in Q1 2026 per DBVT's latest filing, from -$35.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.6 million in Q1 2022 and bottomed at -$49.5 million in Q1 2026.
  • The 5-year median for Free Cash Flow is -$22.9 million (2024), against an average of -$24.4 million.
  • The widest annual swing landed in 2022, when Free Cash Flow soared 95.56%; it then plunged 1198.14% in 2023.
  • Tracing DBVT's Free Cash Flow over 5 years: stood at -$23.9 million in 2022, then surged by 41.26% to -$14.0 million in 2023, then advanced by 13.61% to -$12.1 million in 2024, then sank by 193.11% to -$35.5 million in 2025, then slumped by 39.26% to -$49.5 million in 2026.
  • Per Business Quant, the three latest DBVT Free Cash Flow figures stand at -$49.5 million (Q1 2026), -$35.5 million (Q4 2025), and -$32.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.67 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -12.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -2.49 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.29 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 848.30 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 48.67 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -49.50 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -49.50 Mn
Mar 31, 2026 -49.50 Mn
Dec 31, 2025 -35.55 Mn
Dec 31, 2025 -35.55 Mn
Sep 30, 2025 -32.55 Mn
Sep 30, 2025 -32.55 Mn
Jun 30, 2025 -33.92 Mn
Jun 30, 2025 -33.92 Mn
Mar 31, 2025 -19.70 Mn
Mar 31, 2025 -19.70 Mn
Dec 31, 2024 -12.13 Mn
Dec 31, 2024 -12.13 Mn
Sep 30, 2024 -22.85 Mn
Sep 30, 2024 -22.85 Mn
Jun 30, 2024 -35.81 Mn
Jun 30, 2024 -35.81 Mn
Mar 31, 2024 -36.03 Mn
Mar 31, 2024 -36.03 Mn
Dec 31, 2023 -14.04 Mn
Dec 31, 2023 -14.04 Mn
Sep 30, 2023 -19.62 Mn
Sep 30, 2023 -19.62 Mn
Jun 30, 2023 -25.72 Mn
Jun 30, 2023 -25.72 Mn
Mar 31, 2023 -20.95 Mn
Mar 31, 2023 -20.95 Mn
Dec 31, 2022 -23.90 Mn
Dec 31, 2022 -23.90 Mn
Sep 30, 2022 -20.42 Mn
Sep 30, 2022 -20.42 Mn
Jun 30, 2022 -10.49 Mn
Jun 30, 2022 -10.49 Mn
Mar 31, 2022 -1.61 Mn
Mar 31, 2022 -1.61 Mn
Dec 31, 2021 -19.70 Mn
Dec 31, 2021 -19.70 Mn
Sep 30, 2021 -22.94 Mn
Sep 30, 2021 -22.94 Mn
Jun 30, 2021 -30.13 Mn
Jun 30, 2021 -30.13 Mn
Mar 31, 2021 -36.39 Mn
Mar 31, 2021 -36.39 Mn
Dec 31, 2020 -33.53 Mn
Dec 31, 2020 -33.53 Mn
Sep 30, 2020 -42.23 Mn
Sep 30, 2020 -42.23 Mn
Mar 31, 2020 -50.50 Mn
Mar 31, 2020 -50.50 Mn
Dec 31, 2019 56.60 Mn
Dec 31, 2019 56.60 Mn
Sep 30, 2019 -116.46 Mn
Sep 30, 2019 -116.46 Mn
Jun 30, 2019 -84.33 Mn
Jun 30, 2019 -84.33 Mn
Dec 31, 2018 -150.56 Mn
Dec 31, 2018 -150.56 Mn
Sep 30, 2018 -118.97 Mn
Sep 30, 2018 -118.97 Mn
Jun 30, 2018 -77.18 Mn
Jun 30, 2018 -77.18 Mn
Dec 31, 2017 -126.07 Mn
Dec 31, 2017 -126.07 Mn
Dec 31, 2016 -55.66 Mn
Dec 31, 2016 -55.66 Mn
Dec 31, 2015 -13.64 Mn
Dec 31, 2015 -13.64 Mn
Dec 31, 2014 -13.09 Mn
Dec 31, 2014 -13.09 Mn